Reply to M. Nayan et al

J Clin Oncol. 2018 Feb 20;36(6):629-630. doi: 10.1200/JCO.2017.76.7186. Epub 2017 Dec 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Denmark
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Male
  • Prostatic Neoplasms*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors